Search

everythinglearnresearchcommunity

for

Search:↓

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Sublingual minoxidil is a safe and effective treatment for hair loss, especially in women.

Environmental pollutants can damage hair health and cause hair loss.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Hair follicles help attract immune cells to the skin during stress.

Hair follicles help skin immune recovery after UVB exposure.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Both cell and non-cell parts are important for rat whisker follicle regrowth.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Scalp cooling effectively reduces hair loss from chemotherapy.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Higher early lead exposure is linked to delayed puberty in girls.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

SCD1 inhibitors can cause skin issues in rodents.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.